BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 25, 2016
View Archived Issues
Braeburn and Camurus expand collaboration and license agreement
Read More
FDA clears Cedars-Sinai to test combination stem cell gene therapy for ALS
Read More
NanoCarrier assumes responsibility for epirubicin micelle development
Read More
Sareum completes feasibility study of TYK2 inhibitors to treat T-ALL
Read More
FDA puts partial clinical hold on enrollment in LADD trials
Read More
Sunovion Pharmaceuticals completes acquisition of Cynapsus Therapeutics
Read More
Novel pathogenic mechanism in C9ORF72-related ALS and FTD
Read More
Bioblast Pharma reports results for phase I trial of trehalose
Read More
Melinta Therapeutics submits NDA to FDA for Baxdela
Read More
FDA and EC grant orphan drug designation to Solid Biosciences' SGT-001
Read More
Gpr17-targeted approaches as novel therapeutic options in demyelination diseases
Read More
FDA clears IND for phase I trials of XMT-1522
Read More
DBV reports topline results from 2-year follow-up study of Viaskin Peanut
Read More
EMA issues positive opinion recommending orphan drug designation for La Jolla's LJPC-401
Read More
Investigators patent pfDHODH inhibitors
Read More
Chinese scientists disclose IDO1 inhibitors
Read More
Mutabilis describes beta-lactamase inhibitors
Read More
FDA grants fast track designation to ATYR-1940 for FSHD
Read More
Japanese researchers develop RISK-1 and/or PKB beta/Akt2 inhibitors
Read More
U.S. scientists present RAS GTPases inhibitors
Read More
FDA places clinical hold on phase III program for Inovio's VGX-3100
Read More
FDA issues new approvals in NSCLC for Keytruda
Read More
New [18F]fluorinated PSMA agents show potential for PET imaging of prostate cancer
Read More
Advaxis announces stage 2 results from phase II trial of axalimogene filolisbac in cervical cancer
Read More
New phase II trial explores use of anti-EGFR-IL-dox in triple-negative EGFR-positive breast cancer
Read More
BioCardia merges with Tiger X Medical
Read More
Genetic variants in genes related to pain sensitivity may have a role in EDS
Read More
Investigators identify novel mutations in Pompe disease
Read More